Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone plus propofol for sedation and recovery in elderly patients undergoing intestinal ESD
ChiCTR2500107386Phase 4Not yet recruiting
- Sponsor
- Chengdu Second People's Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone (4 arms), sponsored by Chengdu Second People's Hospital. Primary endpoint: Quality of Recovery (QoR-15) score. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
oxycodone
Beyond the preview
Go deeper on ChiCTR2500107386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107386.